Hazel O’Sullivan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 2
- Cutaneous Melanoma Detection and Management 1
-
- Protein Degradation and Inhibitors 1
- FOXO transcription factor regulation 1
- Melanoma and MAPK Pathways 1
- Co-authors
- Fergal C. Kelleher (5 shared papers)Elizabeth Smyth (1 shared paper)Ray McDermott (1 shared paper)Séamus O’Reilly (3 shared papers)Dearbhaile Catherine Collins (2 shared papers)Richard Bambury (2 shared papers)Derek G. Power (2 shared papers)Delwood C. Collins (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Lung Cancer (1 paper)Oncotarget (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- IrelandNew ZealandUnited Kingdom
In The Last Decade
Hazel O’Sullivan
9 papers receiving 284 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 71
- Oncology 87
- Molecular Biology 183
- Immunology 42
- Pulmonary and Respiratory Medicine 49
Countries citing papers authored by Hazel O’Sullivan
This map shows the geographic impact of Hazel O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel O’Sullivan more than expected).
Fields of papers citing papers by Hazel O’Sullivan
This network shows the impact of papers produced by Hazel O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel O’Sullivan. The network helps show where Hazel O’Sullivan may publish in the future.
Co-authors
The 16 scholars most cited alongside Hazel O’Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 106 | |
| 2 | 2017 | 57 | |
| 3 | 2019 | 52 | |
| 4 | 2016 | 50 | |
| 5 | 2024 | 9 | |
| 6 | 2013 | 7 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 2 | |
| 9 | 2017 | 1 | |
| 10 | 2022 | 0 |
About Hazel O’Sullivan
Hazel O’Sullivan is a scholar working on Oncology, Molecular Biology, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 288 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Protein Degradation and Inhibitors (1 paper), Teratomas and Epidermoid Cysts (1 paper), Cutaneous Melanoma Detection and Management (1 paper), FOXO transcription factor regulation (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Cancer Research (71 citations), Oncology (87 citations), Molecular Biology (183 citations), Immunology (42 citations) and Pulmonary and Respiratory Medicine (49 citations). Hazel O’Sullivan has collaborated with scholars based in Ireland, New Zealand and United Kingdom. Frequent co-authors include Fergal C. Kelleher, Elizabeth Smyth, Ray McDermott, Séamus O’Reilly, Dearbhaile Catherine Collins, Richard Bambury, Derek G. Power, Delwood C. Collins, Carmel G. Cronin and Helen M. Fenlon. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Lung Cancer, Oncotarget and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.